Crane vs Crane NXT
CR and CXT side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CR and CXT compare
Crane is the larger company, worth 3.4 times as much as Crane NXT ($11.4B against $3.4B).
On earnings, Crane NXT is cheaper: it trades at 24.2× trailing earnings, against 34.0× for Crane.
Crane grew revenue faster over the last twelve months (21.5% versus 17.3% for Crane NXT).
Crane keeps more of each dollar of sales as profit, with a net margin of 12.4% compared with 7.8% at Crane NXT.
Both pay dividends: Crane yields 0.50% and Crane NXT 1.2%.
Crane scores higher on the StockData Score (12 against 10 for Crane NXT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CR | CXT |
|---|---|---|
| Size and price | ||
| Market cap | $11.4B | $3.4B |
| Share price | $198.02 | $58.60 |
| Change, 1 year | 2.5% | −9.8% |
| Change, 5 years | 86.5% | −44.8% |
| Beta (5Y) | 1.01 | 0.98 |
| Employees | 4,100 | 2,200 |
| StockData Score | ||
| Total score | 12 (better) | 10 |
| Valuation score | 1 | 1 |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 2 |
| Health score | 4 | 4 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | 34.0× | 24.2× (better) |
| P/S | 4.2× | 1.9× (better) |
| P/B | 5.1× | 2.7× (better) |
| EV/EBITDA | 20.7× | 8.8× (better) |
| Fair value | $157.38 | $58.32 |
| Margin of safety | −25.8% | −0.48% (better) |
| Growth | ||
| Revenue growth (TTM) | 21.5% (better) | 17.3% |
| Revenue growth, 5Y average | – | −10.8% |
| Net income growth (TTM) | −6.5% (better) | −7.3% |
| EPS growth (TTM) | −6.7% (better) | −7.6% |
| EPS growth, 5Y average | – | −4.1% |
| Profitability | ||
| Gross margin | 41.5% | 42.1% (better) |
| Operating margin | 17.7% (better) | 14.0% |
| Net margin | 12.4% (better) | 7.8% |
| Return on equity | 16.2% (better) | 11.5% |
| Return on invested capital | 16.7% (better) | 16.1% |
| Financial health | ||
| Debt / equity | 0.41 | 0.15 (better) |
| Net debt / EBITDA | 1.05 (better) | −0.10 |
| Interest coverage | 10.0× | – |
| Current ratio | 2.61 (better) | 1.42 |
| Altman Z-score | 5.95 (better) | 1.86 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.50% | 1.2% (better) |
| Payout ratio | 16.8% | 28.7% |
| Years of dividend growth | 1 | 2 (better) |
| Dividend growth, 5Y average | – | −16.9% |
| Shareholder yield | 0.50% | 1.2% (better) |
| Ownership | ||
| Held by institutions | 78.5% | 107% |
| Held by insiders | 1.0% | 0.23% |
| Insider net buying, 12 months | $250K | $1.2M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 2.2% | 15.9% |
Go deeper
- CR stock overview
- CR income statement
- CR valuation and score
- CXT stock overview
- CXT income statement
- CXT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.